COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,046 Articles (21,535 medRxiv, 7,511 bioRxiv)

Most recent first Previous |  Page 2632: Articles 26311-26320  | Next

Vitamin D deficiency as risk factor for severe COVID-19: a convergence of two pandemics
De Smet, D., De Smet, K., Herroelen, P., Gryspeerdt, S., Martens, G. A.
10.1101/2020.05.01.20079376 — Posted: 2020-05-05
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian Centre study on tocilizumab versus standard of care.
Quartuccio, L., Sonaglia, A., McGonagle, D., Fabris, M., Peghin, M., Pecori, D., De Monte, A., Bove, T., Curcio, F., Bassi, F., De Vita, S., Tascini, C.
10.1101/2020.05.01.20078360 — Posted: 2020-05-05
COVIDier: A Deep-learning Tool For Coronaviruses Genome And Virulence Proteins Classification
Habib, P., Alsamman, A. M., Saber-Ayad, M., Hassanein, S. E., Hamwieh, A.
10.1101/2020.05.03.075549 — Posted: 2020-05-05
Computational analysis on the ACE2-derived peptides for neutralizing the ACE2 binding to the spike protein of SARS-CoV-2
lupala, c. s., Kumar, V., li, x., su, x., liu, h.
10.1101/2020.05.03.075473 — Posted: 2020-05-04
Computational methods to develop potential neutralizing antibody Fab region against SARS-CoV-2 as therapeutic and diagnostic tool
Manikyam, H. K., Joshi, S. K.
10.1101/2020.05.02.071506 — Posted: 2020-05-04
Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
Laha, S., Chakraborty, J., Das, S., Biswas, S., Manna, S. K., Chatterjee, R.
10.1101/2020.05.03.066266 — Posted: 2020-05-04 Discussion: Onsite
Temporal signal and the phylodynamic threshold of SARS-CoV-2
Duchene, S., Featherstone, L., Haritopoulou-Sinanidou, M., Rambaut, A., Lemey, P., Baele, G.
10.1101/2020.05.04.077735 — Posted: 2020-05-04
Complexity in SARS-CoV-2 genome data: Price theory of mutant isolates
Mandal, S., Singh, R. K. S., Sharma, S. K., Malik, M. Z., Singh, R. K. B.
10.1101/2020.05.04.077511 — Posted: 2020-05-04
Pathogen Reduction Of SARS-CoV-2 Virus In Plasma And Whole Blood Using Riboflavin And UV Light
Ragan, I., Hartson, L., Pidcoke, H., Bowen, R., Goodrich, R. P.
10.1101/2020.05.03.074971 — Posted: 2020-05-04
The UCSC SARS-CoV-2 Genome Browser
Fernandes, J. D., Hinrichs, A. S., Clawson, H., Navarro Gonzales, J., Lee, B. T., Nassar, L. R., Raney, B. J., Rosenbloom, K. R., Nerli, S., Rao, A. A., Schmelter, D., Zweig, A. S., Lowe, T. M., Ares, M., Corbett-Detig, R., Kent, W. J., Haussler, D., Haeussler, M.
10.1101/2020.05.04.075945 — Posted: 2020-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).